Home › Cardiovascular Disease › Vermont › Burlington
Cardiovascular Disease clinical trials in Burlington, VT
4 studies for Cardiovascular Disease are looking for participants at sites in and around Burlington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Product Surveillance Registry
RecruitingObservational study
- Burlington, Burlington
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Recruiting
- The University of Vermont Medical Center, Burlington
ELEVATE-HFpEF Clinical Study
Recruiting
- The University of Vermont Medical Center, Burlington
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Recruiting
- University of Vermont, Burlington
Cardiovascular Disease trials in other cities
- Boston, MA36 studies
- New York City, NY32 studies
- Washington, DC29 studies
- Houston, TX24 studies
- Dallas, TX23 studies
- Cleveland, OH22 studies
- Atlanta, GA22 studies
- Philadelphia, PA21 studies
- Chicago, IL21 studies
- St. Louis, MO20 studies
- Pittsburgh, PA20 studies
- Nashville, TN19 studies
Other studies in Burlington
- Heart Failure8 studies
- Acute Myeloid Leukemia7 studies
- Cancer (all types)6 studies
- COPD5 studies
- Breast Cancer5 studies
- Parkinson's Disease4 studies
- Cystic Fibrosis4 studies
- Prostate Cancer4 studies
- Lung Cancer4 studies
- Leukemia4 studies
- Metastatic Cancer4 studies
- Non-Small Cell Lung Cancer4 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.